Zydus said the monoclonal antibody cocktail ZRC-3308 has been found to be safe and well tolerated in animal toxicology studies and has demonstrated the ability to neutralise SARS-CoV-2 both in vitro and in animal studies.Zydus Cadila seeks permission from DCGI to test its COVID-19 antibody cocktail on humans
Zydus said the monoclonal antibody cocktail ZRC-3308 has been found to be safe and well tolerated in animal toxicology studies and has demonstrated the ability to neutralise SARS-CoV-2 both in vitro and in animal studies.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment